semaglutide mode of action Why is Everyone Talking About the 'Glutide' Drugs as a Treatment for Obesity? Semaglutide (Wegovy®)

While non-steroidal MRAs have not yet been investigated in type 1 diabetes, based on their observed benefits in type 2 diabetes and their mechanism of action, similar kidney-protective effects are anticipated, emphasising the need for dedicated studies with finerenone in people with type 1 diabetes and CKD, including their use in combination with other repurposed therapies such as SGLT2i and GLP1-RAs

Injection site reactions including temporary redness, swelling, or itching occur occasionally

Rotating injection sites and using a 29- to 31-gauge needle cuts the incidence

Org Biomol Chem 12(18):29262937 Narayanankutty A (2021) Inhibitory potential of dietary nutraceuticals on cellular PI3K/Akt signaling: implications in cancer prevention and therapy